WuXi XDC Cayman Inc. (HKG:2268)

Hong Kong · Delayed Price · Currency is HKD

58.90

+2.75 (4.90%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	5.94B	4.05B	2.12B	990.42M	311.13M
Pharmaceuticals Growth	46.69%	90.80%	114.44%	218.33%	222.91%
Total	5.94B	4.05B	2.12B	990.42M	311.13M
Total Growth	46.69%	90.80%	114.44%	218.33%	222.91%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
North America	3.03B	1.98B	726.11M	259.52M	5.40M
North America Growth	52.89%	173.10%	179.79%	4706.83%	-
Europe	1.46B	610.21M	459.84M	128.65M	5.27M
Europe Growth	139.47%	32.70%	257.44%	2343.44%	-
China	919.37M	1.13B	849.07M	566.48M	291.10M
China Growth	-18.83%	33.40%	49.89%	94.60%	202.12%
Others	531.82M	326.46M	88.82M	35.78M	9.36M
Others Growth	62.91%	267.54%	148.25%	282.14%	-
Total	5.94B	4.05B	2.12B	990.42M	311.13M
Total Growth	46.69%	90.80%	114.44%	218.33%	222.91%

Source: S&P Global Market Intelligence.